Wall Township, NJ — The IgA Nephropathy (IgAN) Foundation, a nationally recognized nonprofit based in New Jersey, made a major impact at ASN Kidney Week 2025, earning recognition for its growing leadership in research, advocacy, and patient empowerment. The Foundation’s achievements at this year’s conference underscore its role as one of the most influential patient organizations advancing the fight against IgA nephropathy — a chronic kidney disease that affects thousands of individuals worldwide.
At the heart of the Foundation’s presence was Co-Founder and Executive Director Bonnie Schneider, who delivered the prestigious Celeste Castillo Lee Endowed Lectureship, a keynote that resonated deeply with researchers, clinicians, and patient advocates alike. Her address, titled “The Importance of Patient Advocate Partners to Get Discoveries to the Bedside,” emphasized the urgent need for collaboration between scientists and patient-led organizations to accelerate medical breakthroughs and translate them into real-world therapies.
The Foundation also marked another milestone by presenting its first-ever research poster, reflecting a significant step in its ongoing commitment to scientific advancement. This debut not only showcased the Foundation’s expanding research capabilities but also highlighted its mission to bridge the gap between clinical science and patient experience.
In addition, the organization hosted the IgAN Therapies Forum, which gathered global experts to discuss the newest developments in treatment, ongoing clinical trials, and emerging mechanisms of action that could redefine care for patients living with IgA nephropathy. The forum fostered open dialogue on the evolving therapeutic landscape, signaling a new era of collaboration between researchers, healthcare providers, and the patient community.
Founded and headquartered in Wall Township, New Jersey, the IgAN Foundation has become a beacon of hope for patients and families navigating the challenges of this rare kidney condition. Through education, research funding, and advocacy, the Foundation continues to unite the medical and patient communities in pursuit of one shared goal — finding a cure for IgA nephropathy.
Events like ASN Kidney Week, held this year in Houston, Texas, bring together the world’s leading nephrology professionals to share groundbreaking discoveries and discuss the latest scientific advancements. The IgAN Foundation’s presence at such a prestigious event not only amplified its voice on a global scale but also reinforced New Jersey’s standing as a hub for healthcare innovation and patient advocacy.
To explore more stories about groundbreaking health initiatives and community wellness programs across the Garden State, visit Explore New Jersey Health & Wellness.
With its expanding influence and unwavering mission, the IgA Nephropathy Foundation continues to redefine what’s possible when science, compassion, and advocacy come together for a healthier future.
